ReviewWorld journal of gastroenterology2015
Sarcopenia and liver transplant: The relevance of too little muscle mass.
Review in World journal of gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.
- Opportunistic computed tomography-based sarcopenia screening and mortality after liver transplantation: a systematic review and meta-analysis.Revista da Associacao Medica Brasileira (1992) · 2025Pooled it
- Article
- Sarcopenia as a Predictor of Mortality Among Cirrhotic Patients Awaiting Liver Transplantation.International journal of hepatology · 2026Article
- Ultrasound of the rectus femoris as a novel tool to measure sarcopenia in pediatric chronic liver disease.Hepatology communications · 2025Article
- [The role of the musculoadipose status in the assessment of the risk profile before liver transplantation].Chirurgie (Heidelberg, Germany) · 2024Review
- Association of Muscle Mass Loss with Diabetes Development in Liver Transplantation Recipients.Diabetes & metabolism journal · 2024Article
- Radiological assessment of skeletal muscle index and myosteatosis and their impact postoperative outcomes after liver transplantation.Radiology and oncology · 2023Article
- Sarcopenia in chronic viral hepatitis: From concept to clinical relevance.World journal of hepatology · 2023Review
- Muscle quality determined by computed tomography predicts short-term and long-term survival after liver transplantation.Scientific reports · 2023Article
- Low back pain in patients hospitalised with liver cirrhosis- a retrospective study.BMC musculoskeletal disorders · 2023Article
- Nutritional Strategies to Manage Malnutrition and Sarcopenia following Liver Transplantation: A Narrative Review.Nutrients · 2023Review
- Computed tomography measured epicardial adipose tissue and psoas muscle attenuation: new biomarkers to predict major adverse cardiac events and mortality in patients with heart disease and critically ill patients. Part II: Psoas muscle area and density.Anaesthesiology intensive therapy · 2023Review
- Association between hospital acquired disability and post-discharge mortality in patients after living donor liver transplantation.BMC surgery · 2022Article
- Renal dysfunction independently predicts muscle mass loss in patients following liver transplantation.Canadian liver journal · 2022Article
- State of Knowledge on Molecular Adaptations to Exercise in Humans: Historical Perspectives and Future Directions.Comprehensive Physiology · 2022Article
- Nutrition in Patients with Type 2 Diabetes: Present Knowledge and Remaining Challenges.Nutrients · 2021Review
- Radiologic Definition of Sarcopenia in Chronic Liver Disease.Life (Basel, Switzerland) · 2021Review
- Feasibility of Serial Ultrasound Measurements of the Rectus Femoris Muscle Area to Assess Muscle Loss in Patients Awaiting Liver Transplantation in the Intensive Care Unit.Transplantation direct · 2020Article
- Impact of sarcopenia on mortality in patients undergoing liver re-transplantation.World journal of hepatology · 2020Article
- Muscle depletion in cirrhotic patients assessed using computed tomography: a cross-sectional study.Sao Paulo medical journal = Revista paulista de medicina · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Loss of muscle mass and function is a common occurrence in both patients with decompensated cirrhosis and those undergoing liver transplantation. Sarcopenia is associated with morbidity and mortality before and after liver transplantation. The ability of skeletal muscle mass to recover after transplant is questionable, and long term adverse events associated with persistent sarcopenia have not been well studied. Limited data is available examining mechanisms by which decreased muscle mass might develop. It is not clear which interventions might reduce the prevalence of sarcopenia and associated health burdens. However, measures to either decrease portal hypertension or improve nutrition appear to have benefit. Research on sarcopenia in the liver transplant setting is hampered by differing methodology to quantify muscle mass and varied thresholds determining the presence of sarcopenia. One area highlighted in this review is the heterogeneity used when defining sarcopenia. The health consequences, clinical course and potential pathophysiologic mechanisms of sarcopenia in the setting of cirrhosis and liver transplantation are further discussed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.